<DOC>
	<DOCNO>NCT01553435</DOCNO>
	<brief_summary>Effect N-methyl D-aspartate ( NMDA ) receptor antagonist Dextromethorphan Opiods analgesia tolerance Pediatric Intensive Care Unit Patients</brief_summary>
	<brief_title>Effect N-methyl D-aspartate ( NMDA ) Receptor Antagonist Dextromethorphan Opiods Analgesia Tolerance Pediatric Intensive Care Unit Patients</brief_title>
	<detailed_description />
	<mesh_term>N-Methylaspartate</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<criteria>Inclusion : Patients 2 year , admit PICU On Morphine Fentanyl infusion 48 hour Patients 2 year age Patients anticipated PICU length stay le 3 day . Patients shall exclude Morphine Fentanyl infusion continue minimum duration 72 hour enrollment Patients develop hemodynamic instability Patients Hepatic failure Withdrawal request parent ( ) /guardian/family</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Dextromethorphan</keyword>
	<keyword>Morphine</keyword>
	<keyword>Fentanyl</keyword>
	<keyword>Opioid</keyword>
	<keyword>analgesia</keyword>
	<keyword>Efficacy</keyword>
</DOC>